CIK 0001439725
- Non-accelerated filer
- Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203986492
- Phone
- +1 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- 4 Open-market sale President & CEO sold 3,775 shares at an average $0.36 ($1,344)
- 4 Open-market sale CFO, Sec'y & Treasurer sold 992 shares at an average $0.36 ($353)
- 4 Exercise or conversion Director acquired 26,368 shares (option exercise)
- 4 Exercise or conversion Director acquired 46,686 shares (option exercise)
- 4 Exercise or conversion Director acquired 46,686 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Accounting Officer sold 3,630 shares at $0.92 ($3,355)
- 4 Open-market sale Chief Development Officer sold 16,748 shares at $0.92 ($15,479)
- 4 Open-market sale Chief Commercial Officer sold 17,527 shares at $0.92 ($16,198)
- 4 Open-market sale President & CEO sold 83,660 shares at $0.92 ($77,319)
- 4 Open-market sale CFO, Sec'y & Treasurer sold 24,664 shares at $0.92 ($22,794)
- 4 Open-market buy Director bought 100,000 shares at $1.23 ($122,840)
- 4 Open-market buy Director bought 35,000 shares at $1.16 ($40,562)
- 4 Open-market buy Director bought 200,000 shares at $1.17 ($234,000)
- 4 Open-market sale Chief Accounting Officer sold 203 shares at an average $1.40 ($283)
- 4 Open-market sale Chief Development Officer sold 427 shares at an average $1.40 ($596)
Page 4 of 17 · 336 filings